Current medical understanding does not provide robust support for dosing regimens of lamivudine or emtricitabine in children with HIV and chronic kidney disease (CKD). The potential of physiologically based pharmacokinetic models for determining the optimal dose in this group of patients is noteworthy. Within Simcyp (version 21), the existing lamivudine and emtricitabine compound models were evaluated in adult populations with and without CKD, and in non-CKD paediatric populations. Using adult CKD population models as a foundation, we developed pediatric CKD models that reflect individuals with reduced glomerular filtration and impaired tubular secretion. To verify these models, ganciclovir was employed as a proxy compound. Simulation of lamivudine and emtricitabine dosing was performed within virtual models of pediatric chronic kidney disease populations. Navarixin antagonist Validation of the compound and paediatric CKD population models proved successful, resulting in prediction errors remaining within the 0.5 to 2-fold range. In children with chronic kidney disease (CKD), comparing GFR-adjusted doses in the CKD population to standard doses in a population with normal kidney function, the mean AUC ratios for lamivudine were 115 and 123, and for emtricitabine were 120 and 130, respectively, in CKD stages 3 and 4. Employing PBPK models in pediatric CKD populations, the GFR-adjusted dosages of lamivudine and emtricitabine in children with CKD successfully maintained appropriate drug exposure, thus reinforcing the efficacy of paediatric GFR-adjusted dosing. To ascertain the accuracy of these observations, clinical research is imperative.
A key challenge in treating onychomycosis with topical antifungals is the poor penetration rate of the antimycotic through the nail plate. A novel transungual system for delivering efinaconazole effectively, through the use of constant voltage iontophoresis, is being conceptualized and developed in this research. genetic lung disease For assessing the influence of solvent (ethanol) and cosolvent (Labrasol) on transungual delivery, seven prototype drug-loaded hydrogel formulations (E1 to E7) were fabricated. To determine the impact of three independent variables – voltage, solvent-to-cosolvent ratio, and penetration enhancer (PEG 400) concentration – on critical quality attributes (CQAs) such as drug permeation and nail loading, optimization was performed. Characterization of the selected hydrogel product included its pharmaceutical properties, efinaconazole release from the nail, and antifungal activity. Pilot studies indicate that the interplay of ethanol, Labrasol, and applied voltage might influence the transungual absorption rate of efinaconazole. The optimization design demonstrates a profound effect of applied voltage (p-00001) and enhancer concentration (p-00004) on the CQAs' characteristics. A high desirability value, 0.9427, confirmed the substantial correlation between the chosen independent variables and CQAs. Significant (p < 0.00001) improvements in both permeation (~7859 g/cm2) and drug loading (324 g/mg) were observed with the optimized 105 V transungual delivery system. FTIR data confirmed a lack of interaction between the drug and excipients, and DSC data validated the amorphous form of the drug in the formulation. Within the nail, iontophoresis establishes a drug depot releasing consistently above the minimum inhibitory concentration for an extensive duration, potentially decreasing the need for frequent topical treatments. Remarkable inhibition of Trichophyton mentagrophyte, as displayed by antifungal studies, serves to further substantiate the release data. Considering the results, this non-invasive method shows strong prospects for the efficient transungual delivery of efinaconazole, a potential advancement in the treatment of onychomycosis.
Lyotropic nonlamellar liquid crystalline nanoparticles (LCNPs), specifically cubosomes and hexosomes, exhibit effective drug delivery properties due to their distinctive structural features. Within a cubosome, a lipid bilayer creates a membrane lattice, incorporating two interlinked water channels. Hexosomes, an inverse hexagonal phase, are constructed from an infinite number of hexagonal lattices. These lattices are firmly bonded and permeated with water channels. To ensure stability, these nanostructures are frequently treated with surfactants. The structure's membrane's surface area greatly exceeds that of other lipid nanoparticles, thereby enabling the inclusion of therapeutic molecules. Pore diameters within mesophases can be modified, and this, in turn, affects how medication is released. Over recent years, significant research has been undertaken to develop improved preparation and characterization techniques, alongside controlling the release of drugs and increasing the effectiveness of the loaded bioactive chemicals. This review examines the latest progress in LCNP technology, enabling its application, and proposes design ideas for revolutionary biomedical applications. Furthermore, we have compiled a summary of LCNP applications, categorized by the method of administration, and highlighting their pharmacokinetic modulation capabilities.
The skin's ability to control permeability to external substances demonstrates a complex and selective mechanism. The exceptional performance of microemulsion systems is evident in the encapsulation, protection, and transdermal delivery of active compounds. Microemulsion systems' low viscosity and the importance of smooth application in both cosmetic and pharmaceutical products are reasons for the rising demand for gel microemulsions. The goal of this investigation was twofold: first, to design new microemulsion systems for topical use; second, to ascertain the optimal water-soluble polymer for producing gel microemulsions; and finally, to examine the effectiveness of the developed microemulsion and gel microemulsion systems in delivering the model active ingredient, curcumin, into the skin. A pseudo-ternary phase diagram was generated using a surfactant mix consisting of AKYPO SOFT 100 BVC, PLANTACARE 2000 UP Solution, and ethanol; caprylic/capric triglycerides from coconut oil constituted the oily phase; and distilled water was utilized. By employing sodium hyaluronate salt, gel microemulsions were successfully produced. Stereotactic biopsy These ingredients are safe for skin application and completely biodegradable. Rheometric measurements, along with dynamic light scattering, electrical conductivity, and polarized microscopy, were employed to characterize the selected microemulsions and gel microemulsions physicochemically. To assess the effectiveness of the chosen microemulsion and gel microemulsion in delivering encapsulated curcumin, an in vitro permeation study was undertaken.
Strategies for reducing bacterial infections, including their virulence factors and biofilm formation, are evolving, aiming to diminish the dependence on existing and forthcoming antimicrobial and disinfectant agents. Strategies currently employed to mitigate the severity of periodontal disease, stemming from pathogenic bacteria, through the use of beneficial microorganisms and their metabolic products, are highly advantageous. Selected probiotic lactobacilli strains, originating from Thai-fermented foods, had their postbiotic metabolites (PM) isolated. These PMs displayed inhibitory activity against periodontal pathogens and their biofilm. The selection process from 139 Lactobacillus isolates resulted in the choice of the Lactiplantibacillus plantarum PD18 (PD18 PM) strain, which had the most pronounced antagonistic effect on Streptococcus mutans, Porphyromonas gingivalis, Tannerella forsythia, and Prevotella loescheii. The minimal inhibitory concentration (MIC) and minimum biofilm inhibitory concentration (MBIC) of PD18 PM on the pathogens spanned the values from 12 to 14. The PD18 PM effectively inhibited biofilm formation by both Streptococcus mutans and P. gingivalis, exhibiting a noteworthy decrease in viable cells, substantial percentages of biofilm inhibition reaching 92-95% and 89-68%, respectively, and optimal contact periods of 5 minutes and 0.5 minutes respectively. A natural adjunctive agent, L. plantarum PD18 PM, demonstrated potential in inhibiting periodontal pathogens and their biofilms.
Small extracellular vesicles (sEVs) have been lauded as the next generation in drug delivery systems, excelling over lipid nanoparticles in their numerous advantages and immense potential. Milk is reported by studies to hold a high concentration of sEVs, making it a considerable and economical resource for collecting these vesicles. Naturally occurring, milk-derived small extracellular vesicles (msEVs) showcase a range of significant biological actions, including immunomodulation, anti-microbial efficacy, and antioxidant properties, positively influencing human health through various pathways, such as maintaining intestinal health, bone/muscle metabolic functions, and controlling gut microbiota. Ultimately, given their proficiency in navigating the gastrointestinal barrier and their low immunogenicity, coupled with their notable biocompatibility and stability, msEVs are recognized as a critical component of oral drug delivery. Moreover, targeted delivery of drugs by msEVs can be achieved through further engineering, thereby increasing their circulation time or strengthening local drug concentrations. The separation and purification of msEVs, combined with the intricacy of their composition and the stringent standards of quality assurance, present critical hurdles in their application as components of drug delivery systems. The biogenesis, characteristics, isolation, purification, composition, loading methods, and functions of msEVs are meticulously examined in this paper, which then explores their applications in various biomedical contexts.
Continuous processing using hot-melt extrusion is becoming more prevalent in the pharmaceutical industry, allowing for the tailored creation of medicines by combining active pharmaceutical ingredients with specialized excipients. The residence time and temperature profile during extrusion are critical for optimal product quality, particularly for thermosensitive materials, within this context.